Update by IDA Foundation Leontien Ruttenberg MSc MBA.

Slides:



Advertisements
Similar presentations
MDG Target 8.E gap analysis Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical Policies, World Health Organization 27 August 2008.
Advertisements

National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
AMDS Contribution to the Technical Briefing Seminar October 2007.
THE INTERNATIONAL DRUG PURCHASE FACILITY-UNITAID Michel D. Kazatchkine, Ministère des Affaires Etrangères, France.
Procurement is a hot topic! So is Supply Management – but for today we will focus on procurement IHP+ Country Health Sector Teams Meeting, Nairobi, Kenya11-14.
Access to Medicines: what should the industry contribute? Part II: Supply Chain & Delivery Systems - The Last Mile Challenge EFPIA 18 th September 2013.
Pharmaceuticals Procurement and Supply Management: The case of Ethiopia Cambodia, December 4,
Workshop 2 Supply reasons Solutions for medicines shortages.
Working Together to Improve Global Health
UNITAID Innovative Financing Mechanism  Denis Broun Executive Director.
Mexico International AIDS Conference Global Architecture of HIV/AIDS Financing Remarks by Joy Phumaphi, Vice President of the World Bank’s Human Development.
Pharmaceuticals and Global Health: Successes, Challenges and Outlook 19. July 2013, University of Sussex Thomas B. Cueni, Secretary General Interpharma.
Global Health Supply Chains Prashant Yadav. Yadav. Global Health Supply Chains 2 The health production process.
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
Health Professional Students AIDS Advocacy Network Treat the People: Access to Essential AIDS Medications A Primer for Health Professional Students.
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
Supply Chains Management for Pharmacy
1 Collective Efficiencies Development Finance Architecture Workshop Prerna Banati - July
Update to IPC on MODEL QUALITY ASSURANCE SYSTEM FOR PROCUREMENT AGENCIES (MQAS) Dr Sabine Kopp 16 December 2014 Update to IPC on MODEL QUALITY ASSURANCE.
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Pharmaceutical Services Unit Essential Medicines Management MoH Procurement of Essential Medicines Presented by Mildred Mulenga Pharmacist, MoH 1.
Msd medical stores department MEDICAL STORES DEPARTMENT : Performance Overview: Presented to DPG Cosmas Mwaifwani Ag Director General 12, April,
Ashley Morris Erica Shnayder Adam Percy Nana Sang-Bender.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
TBS November | Medicines Supply Systems strengthening : Challenges Dr Magali Babaley, Dr Helen Tata, Dr Helene Moller Essential Medicines.
Procurement and Supply Management in Moldova Laurentiu IONESII.
Managing Risk and Overcoming Health Systems Bottlenecks in Haiti Emerging Lessons Jessica Faieta - Senior Country-Director, UNDP/Haiti & Dr Joelle Deas.
AIM 2030 Access to Innovative Medicines Draft concept for a new World Bank-led multi-stakeholder initiative August 2014, Andreas Seiter.
Update on prequalification of essential medicines for reproductive health Dr Hans V. Hogerzeil Director Medicines Policy and Standards WHO, Geneva Reproductive.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
BSP Contraceptive Initiative To broaden sustainable access to quality hormonal contraceptives through a new commercial venture Reproductive Health Supplies.
Wilbert Bannenberg SARPAM
Integrated Supply Chain Management in Public Health The All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases 16 October, 2012; Portcullis.
Cambodia1. 2 Cambodia Assessment Ung Phirun Chroeng Sokhan.
Achieving Excellence in the Supply Chain Workforce: The People that Deliver Global Partnership.
WORLD HEALTH ORGANIZATION THE WORLD BANK ARV and related drugs Supply Chain Management AIDS Campaign Team for Africa (ACTafrica) The World Bank Africa.
Veiovis LifeSciences Pvt Ltd
Access to Medicines- OHCHR Geneva, October 11, 2010 Access to Medicines- the Global Fund Experience Pharmaceutical Management Unit October 11, 2010.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
1 AccessRH Presentation to RHSC by Morten Sorensen, Deputy Chief Procurement Services Branch Kampala, Uganda, 28 May 2010.
Price Considerations for TB Drugs. Goals of Effective Procurement Selecting appropriate medicines Meeting required quality standards In right quantities.
CENTRAL MEDICAL STORES Merapelo Baruti CMS Deputy Manager.
Experience with common basket for ARV procurement Tanzania Emma Lekashingo Msuya.
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
CO “All-Ukrainian Network of People Living with HIV” Potential Problems in Supply – What Can Be Done? Kyiv, 2008.
Quality Assurance for pharmaceutical products in international procurement Approach of major donors and procurers Core presentation prepared by Sophie.
2004: 39.4 (35.9 – 44.3) million Western & Central Europe [ – ] North Africa & Middle East [ – 1.5 million] Sub-Saharan.
UNOPS United Nations Office for Project Services Presenter: Therese Ballard Director, Sustainable Procurement Practice Group Meeting: Meet the UN agencies.
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
RHSC Meeting, London RHSC Meeting, London Tanzania : Contraceptive Security Committee Michael Mushi USAID, Tanzania.
Opportunities in 2012 and Beyond The Way Forward Stuart Semple Director of Pharmacy and Medicines Management Barts Health NHS Trust.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Al Noor Drug Store Amman- Jordan Established in 2001.
Strengthening HIV Responses through Private Sector Involvement in Supply Chain Management Medical Access Experience in Uganda Sowedi Muyingo 1, James Olweny.
KAZAKH PHARMACEUTICAL COMPANY “MEDSERVICE PLUS” LLP 2016.
Wilbert Bannenberg SARPAM
Pharmacoeconomics of generics
Procurement and Supply Management Policies
Expanding ARV treatment in developing countries: Issues and Prospects
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Health Supply Chain Management: Session 6: Facilities, Staffing and Procurement Ghana Nursing Schools.
World Health Organization
Key question: Do we have the mechanisms in place to scale up external funding for data and to accelerate innovation & learning?
Global Drug Facility: Providing Access to Medicines and Commodities for Tuberculosis Thomas Moore Manager GDF Geneva, 19 November 2009.
Prequalification Programme of Medicines (PQP): Introductory messages
Prequalification of HIV/AIDS products and manufacturers
Presentation transcript:

Update by IDA Foundation Leontien Ruttenberg MSc MBA

Our mission: “To improve access to and deliver high-quality medicines and medical supplies at the lowest possible price to low and middle income countries.” Introducing IDA Foundation …a not-for-profit supplier of essential medicines and medical supplies since 1972

Customers in 130+ countries 40+ agents worldwide & 10 locations with stock Head office in Amsterdam (110 employees) Procurement office in Mumbai (65 employees) IDA Foundation: global presence

Customers and partners MULTILATERAL FUNDING MULTILATERAL PROGRAM & FUNDING The Global Fund to Fight Aids, Tuberculosis and Malaria Drug-purchasing facility (provides funding grants) Hosted by WHO The World Bank World Health Organisation BILATERAL NGO & PRIVATE FOUNDATIONS PRESIDENT’S MALARIA INITIATIVE (PMI) President’s Emergency Plan for AIDS Relief (PEPFAR) Clinton Health Access Initiative (CHAI) GLOBAL DRUG FACILITY (GDF) The Global Health Network National Ministries of Health (MoH) Local NGOs Central Medical Stores

Multi-channel approach Procurement Services, wholesale & tender proposals Portfolio of > 3000 products Stock keeping 750 products Average stock value: € 12 million Increased turnover over the years with customer ranging from hospitals to large donors Emergency response 4 Global PA contracts (GDF (2), CHAI, PPM) 2 National PA contracts(Togo, Nigeria) 30 Audits IDA Foundation : key facts 2014

Guaranteed quality for pharmaceuticals and medical supplies* (*process may vary depending on risk class) More than quality control ‘on paper’  verification audits, samples Leading in quality innovation: role in MQAS, WHO working groups Own product: registrations in destination country Dedicated pharmacists in our QA / QC teams in NL, Mumbai, China IDA Quality

Update on achievements 2014 Product range: RMNCH: reviewed portfolio to include UN 13 commodities NCD: reviewed portfolio, added 26 anti-cancer drugs to be completed in Q1, 2015 HIV/AIDS ; increased focus – re-establish value added Quality Bioequivalence studies Supply Chain Management Custom – made kitting projects / more complex supply chain solutions

Update on challenges 2014 Product range: Stock keeping, shelf-life requirements, lead time Local manufacturing – price differences w/ Asian generics Registration Lack of standardization in medical devices No standard list No standard quality guidelines Quality Bioequivalence studies Harmonization QA guidelines Focus on local manufacturers may jeopardize uniformity (eg Universal) Complying to different standards costs time/donor money

Any Questions / Feedback? Contact: Join us on: IDA.Foundation.Amsterdam IDA_Foundation

Summary IDA continues to passionately serve unmet needs Not for profit, independant & transparant Looking forward to increased harmonization Partnership approach